N/A N=347 Randomized Single-blind Treatment

Mental Health Assessment Project on the Thailand-Burma Border

Depression · Anxiety · Posttraumatic Stress

Bottom Line

View on ClinicalTrials.gov: NCT01459068 ↗

Enrolled (actual)

347

Serious AEs

0.0%

Results posted

Jun 2014

Primary outcome: Primary: Depression — -0.52; -1.02 units on a scale — p=<0.001

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Common Elements Treatment Approach (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Johns Hopkins Bloomberg School of Public Health
Primary completion: Nov 2012

Outcome Measures

Outcome	Result	p-value
PRIMARY Depression	-0.52; -1.02	<0.001 sig
PRIMARY Posttraumatic Stress Symptoms	-0.38; -0.80	<0.001 sig
SECONDARY Functional Impairment	-0.20; -0.64	<0.001 sig
SECONDARY Anxiety Symptoms	-0.42; -0.90	<0.001 sig
SECONDARY Aggression Behaviors	-0.22; -0.47	<0.001 sig
SECONDARY Alcohol Use	-1.29; -1.25	0.896

Summary

The aim of the study is to determine the effectiveness of a transdiagnostic psychotherapy intervention - namely, Common Elements Treatment Approach (CETA) - in reducing the severity of mental health symptoms experienced by torture and violence survivors displaced from Burma into Thailand. Specifically, the intervention seeks to measure reductions (if any) in symptoms of depression and trauma.

Eligibility Criteria

Inclusion Criteria

Burmese national, 18 or over, living in Thailand outside of refugee camps, meets or exceed the algorithm for the Hopkins Symptoms Checklist 25 (HSCL-25) depression subscale and/or the algorithm for the Harvard Trauma Questionnaire (HTQ) posttraumatic stress scale.

Exclusion Criteria

not Burmese national, under 18, not living in Thailand outside of refugee camps, does not meet meet or exceed the algorithm for the Hopkins Symptoms Checklist 25 (HSCL-25) depression subscale and/or the algorithm for the Harvard Trauma Questionnaire (HTQ) posttraumatic stress scale; active psychosis

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01459068). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.